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The pathophysiology of the E150K mutation in the rod opsin gene associated with autosomal recessive reti-
nitis pigmentosa (arRP) has yet to be determined. We generated knock-in mice carrying a single nucleotide 
change in exon 2 of the rod opsin gene resulting in the E150K mutation. This novel mouse model displayed 
severe retinal degeneration affecting rhodopsin’s stabilization of rod outer segments (ROS). Homozygous 
E150K (KK) mice exhibited early-onset retinal degeneration, with disorganized ROS structures, autofluores-
cent deposits in the subretinal space, and aberrant photoreceptor phagocytosis. Heterozygous (EK) mice dis-
played a delayed-onset milder retinal degeneration. Further, mutant receptors were mislocalized to the inner 
segments and perinuclear region. Though KK mouse rods displayed markedly decreased phototransduction, 
biochemical studies of the mutant rhodopsin revealed only minimally affected chromophore binding and G 
protein activation. Ablation of the chromophore by crossing KK mice with mice lacking the critical visual cycle 
protein LRAT slowed retinal degeneration, whereas blocking phototransduction by crossing KK mice with 
GNAT1-deficient mice slightly accelerated this process. This study highlights the importance of proper higher-
order organization of rhodopsin in the native tissue and provides information about the signaling properties 
of this mutant rhodopsin. Additionally, these results suggest that patients heterozygous for the E150K muta-
tion should be periodically reevaluated for delayed-onset retinal degeneration.
Introduction
Rod opsin, an apoprotein that combines with the chromophore 
11-cis-retinal to form the light-sensitive visual pigment rhodop-
sin, is critical for visual functioning of the retina (1, 2). Rhodop-
sin localizes at a 5-mM concentration in specific ciliary structures 
called rod outer segments (ROS) (3). This high level of protein 
along with the continuous renewal of ROS (4) imposes a tremen-
dous burden on these postmitotic photoreceptor neurons, which 
in turn can affect the neighboring retinal pigmented epithelium 
(RPE). Consequently, even structurally minor mutations in the 
opsin gene could cause rod cell instability, aberrant signaling, or 
defects in intracellular trafficking that could potentially extend 
to other retinal layers and lead to a host of visually handicapping 
diseases, including retinitis pigmentosa (RP).
RP is the name of a heterogeneous group of hereditary retinal 
degenerative diseases that primarily affect rod photoreceptor cells 
(5) (RetNet, https://sph.uth.edu/RetNet/. RP affects over 1 mil-
lion individuals worldwide and an estimated 100,000 people in the 
United States. Symptoms such as decreased vision under low light 
and loss of peripheral visual field classified as “tunnel vision” often 
first appear in childhood, but severe visual problems such as loss of 
central vision do not usually develop until early adulthood. Due to 
the lack of a detailed understanding of RP pathophysiology, only a 
few experimental therapeutic approaches have been developed (e.g., 
refs. 6–10), with no clinically effective treatment available to date. 
RP can be caused by mutations in more than 50 genes encoding 
photoreceptor cell proteins with an autosomal dominant (adRP), 
autosomal recessive (arRP), or X-linked pattern of inheritance. 
More than 100 mutations have been associated with RP in the 
single gene that encodes rod opsin (11–13). Most of these muta-
tions cause adRP, accounting for 30%–40% of the total RP cases, 
whereas only a few, including severe truncation of the opsin gene 
(14), are inherited in an autosomal recessive pattern. The c.448G>A 
(p.E150K) mutation in patients was the first reported missense 
mutation in the opsin gene associated with arRP (15, 16), and the 
resulting mutant protein has since been characterized in vitro by 
biochemical methods (17, 18). Another mutation that causes arRP, 
G284S, is listed in RetNet, but without further biochemical charac-
terization. Thus, it remains to be understood how missense muta-
tions give rise to arRP in humans. Studies of RP mutations in the 
opsin gene can teach us about the structure and function of this 
key visual protein and the cell biology of one of the most metaboli-
cally active neurons, namely the rod photoreceptor cell.
The size of ROS has been shown to be proportional to the level 
of opsin expression. Heterozygote opsin knockout mice displayed 
no overt disease phenotype apart from a reduced disc diameter 
(19), whereas overexpression of opsin in rods increased outer 
segment diameters to accommodate the extra protein (20). Fur-
thermore, rods from homozygous opsin-knockout mice failed to 
develop outer segments (21, 22). Thus, available evidence indicates 
that rhodopsin stabilizes the outer segment structure of rod cells, 
in addition to its primary function in phototransduction. There 
are several mechanisms potentially leading to disease in E150K 
patients. The E150K mutation substituting a positively charged 
Lys for the negatively charged Glu residue could result in disrup-
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tion of the higher-order organization of rhodopsin (19, 23–25) or 
cause aberrant transport of this protein to the ROS (17, 18). Even 
if the protein can properly traffic and oligomerize in rod discs, the 
crystal structure of rhodopsin (26) indicates that residue 150 inter-
acts with Arg69 in the loop connecting helices I and II (C-I loop), 
and because almost the entire cytoplasmic surface of rhodopsin is 
engaged in the interaction with its G protein transducin (27, 28), 
signaling by the mutant protein could also be defective. To under-
stand the pathophysiology of arRP, one must first have a model 
for study that approximates the human condition.
Hypotheses regarding the pathophysiology of RP from previ-
ous data should be made with care, because results obtained with 
cell culture systems do not always correlate with the in vivo dis-
ease state of RP. Previous studies of adRP have shown that opsin 
Figure 1
Rhodopsin models and targeting strategy and molecular characterization of E150K knock-in mice. (A) 2D model of rhodopsin indicate residue 
conservation and mutations that cause human adRP and arRP. Figure adapted with permission from Science (26). The E150K mutation is located 
at the interface of the cytoplasmic side with the disc membrane, close to the putative dimerization site indicated by arrows in the (B) 3D model 
of bovine rhodopsin. Figure adapted with permission from the Journal of Structural Biology (71). (C) E150K knock-in mice were generated by 
using a targeting vector containing a 2.11-kb 5′ short homology arm (SA) and a 5.36 kb long homology arm (LA). A loxP-flanked Neo cassette was 
upstream of exon 2. The target 284-bp sequence region included a G to A transversion at codon 150 in exon 2 (star). Codon 150 in exon 2 was 
changed to AAG by homologous recombination, and the flipase recognition target loxP-flanked Neo cassette was inserted before exon 2. The Neo 
cassette was removed by Cre-loxP recombination to generate E150K opsin knock-in mice. Whole-locus sequencing confirmed the knock-in (KI). 
This mouse retained a 44-bp loxP sequence in the intron between exons 1 and 2. (D) PCR primers were designed to amplify the intron where 
the 44-bp loxP sequence was inserted. The WT allele and E150K opsin allele produced 262- and 306-bp PCR products, respectively, whereas 
the negative control displayed no template contamination. (E) Chromatogram of opsin cDNA of 2 clones from one 15-day-old EK mouse retina 
confirmed the presence of both mutant and WT mRNAs.
Downloaded on October 19, 2013.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/66176
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 1   January 2013 123
knock-in mice can mimic the human phenotype and reveal the 
pathophysiology of RP in vivo (29). Therefore, we used a gene tar-
geting strategy to develop knock-in mice in which Glu(E)150 is 
replaced by Lys(K)150. We employed multiple techniques to track 
gross morphological and physiological changes in the eye to show 
that this knock-in mouse model best mimics the genetic condition 
affecting E150K RP patients. A set of biochemical assays involving 
isolated photoreceptor membranes and purified rhodopsin from 
WT and mutant mice, as well as high-resolution imaging of the 
retinal layers, revealed that the degenerative phenotype of the lat-
ter is attributable to the structural destabilization of highly orga-
nized ROS disc membranes caused by E150K rhodopsin. Even in 
heterozygote mice, there is diminished visual function and struc-
tural integrity with age, warranting classification of E150K as a 
slowly progressing adRP rather than an arRP.
Results
EK and KK mice exhibit different rates of photoreceptor degeneration. We 
generated E150K opsin knock-in mice by replacing the endogenous 
opsin gene with a mouse opsin gene carrying the E150K mutation 
(Figure 1, A and B). A neomycin (Neo) cassette flanked by loxP sites, 
first introduced into the mouse opsin gene for clonal selection, was 
later removed by electroporation with a Cre-expressing vector to 
generate E150K knock-in mice. The final knock-in allele contained 
the E150K mutation and one 44-bp loxP residue before exon 2 (Fig-
ure 1C). Primers flanking the loxP sequence were used for geno-
typing. WT mice showed a 262-bp PCR product, whereas homo-
zygous E150K (KK) mice showed a 306-bp product; heterozygous 
(EK) mice had both PCR products (Figure 1D). The entire knock-in 
sequence was confirmed by direct sequencing of 9.2-kb PCR prod-
uct amplified by primers located in the original mouse genome 
flanking the knock-in locus (see sequencing data in the Supple-
ment; supplemental material available online with this article; 
doi:10.1172/JCI66176DS1). Sequencing cDNA from EK mice 
revealed transcription of both WT and E150K mRNA (Figure 1E). 
To determine the ratio of WT and E150K mRNA, we sequenced 
more than 120 cDNA clones obtained from 3 mice. Numbers of 
WT and E150K clones were similar, indicating that mRNA levels 
for the E150K and WT opsin were comparable (Table 1).
We tracked global retinal morphologies in vivo by using spec-
tral domain optical coherence tomography (SD-OCT). Represen-
tative 3D reconstruction of OCT images of 2-month-old mouse 
retinas showed thinning of the retina indicative of photoreceptor 
degeneration, especially the outer nuclear layer (ONL) in KK mice 
as compared with age-matched WT mice (Figure 2A). The ONL 
thickness measured from OCT images revealed the progression of 
retinal degeneration in EK and KK mice (Figure 2B). Retinas from 
KK mice rapidly degenerated, and their ONL almost disappeared 
by 4 months of age. Retinal detachment was also evident in some 
regions during OCT examination at this age (data not shown). 
Surprisingly, EK mice also showed retinal degeneration, but with 
a much slower time course, culminating in nearly complete loss of 
ONL by 10 months of age.
Histological analyses of retinas from KK and EK mice revealed 
more detailed morphological changes. At P30, the ONL consisted 
of 9–10 rows of nuclei in both WT and EK mice and 7–8 rows in KK 
mice. Retinal degeneration was rapid in KK mice, such that most 
of the photoreceptors had disappeared by 4 months of age. At this 
age, EK mice also started to lose photoreceptors, as indicated by a 
decline in ONL thickness to 7–8 rows of nuclei (Figure 2C). Retinal 
degeneration did not show regional variance. We cut retinal sec-
tions from 2-month-old mice from either the superior-inferior or 
nasal-temporal directions across the optic nerve head. KK mice, 
with only 3–4 rows of nuclei in the ONL at this age, did not show 
differences in those two directions (Figure 2D). Progressive degen-
eration could cause poor regeneration of rod visual pigment opsin 
in the mutant mice, leading to visual deterioration. To investigate 
this, we studied regeneration with an analog visual chromophore to 
quantify the amount of unregenerated visual pigments.
KK mice display a slight increase in free opsin accumulation. Retinal 
aldehydes were derivatized with hydroxylamine, and the result-
ing syn- and anti-oximes were extracted from 1-month-old mouse 
retinas. The amount of rhodopsin measured by the presence of 
11-cis-retinal oximes in the retina was dramatically reduced in KK 
mice but only modestly decreased in EK mice (Figure 3A), con-
sistent with their differing rates of photoreceptor degeneration. 
To examine the possibility that the observed retinal degenera-
tion resulted from lower amounts of rhodopsin or the presence 
of mutant opsin, we isolated retinas from WT, EK, and KK mice 
and incubated them overnight in PBS alone or buffer contain-
ing 9-cis-retinal added in ethanol to prevent opsin precipitation 
during detergent solubilization in the next step of the procedure 
(30). 9-cis-retinal binds to free opsin in membranes forming stable 
isorhodopsin, and retinoid analysis was used to determine levels 
of regenerated opsin after immunoaffinity purification of rho-
dopsin/isorhodopsin (Figure 3). Trace amounts of 9-cis-retinal 
oximes contaminated with 11,13-di-cis-retinal oxime detected in 
the control samples resulted from thermal isomerization during 
sample handling (Figure 3A). Substantial increases in 9-cis-retinal 
oximes were detected in all regenerated retina samples compared 
with control samples incubated in PBS buffer alone (Figure 3A). 
Quantification of retinoids revealed a 4% greater accumulation of 
9-cis-retinal in retinas isolated from the KK mutant than from WT 
and EK mice (Figure 3B), indicating a small preferential accumula-
tion of free opsin in KK mice. Similar results were obtained in two 
independent experiments. To better understand the role of E150K 
mutation, we purified rhodopsin from retinas of each mouse gen-
otype to assess its folding and activation dynamics.
E150K rhodopsin is properly folded, dimerizes, and activates G protein. 
Absorbance spectra of immunoaffinity-purified rhodopsin from 
WT, EK, and KK mouse eyes revealed similar profiles, indicating 
proper protein folding. The spectrum of rhodopsin purified from 
KK mutant mice exhibited a maximum absorption peak at 498 nm 
in its dark state, indicating proper formation of the Schiff base 
between Lys296 of the opsin and the 11-cis-retinal chromophore. 
Table 1
cDNA ratios of E150K opsin to WT opsin reveal no significant 
differences
Mouse ID No. of E150K clones No. of WT clones
1 26 23
2 19 27
3 16 18
Total 61 68
A total of 129 opsin cDNA clones isolated from retinas of 3 P15 EK mice 
were sequenced and used to identify ratios of E150K and WT opsin to 
subtotal clone numbers in each mouse. No statistically significant differ-
ences were found among E150K and WT opsin ratios.
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Moreover, the KK rhodopsin spectra were similar to the absorbance 
spectra of dark-state rhodopsin purified from WT and EK mice, as 
well as following light illumination and acidification (Supplemen-
tal Figure 1A). Indeed, consistent with proper folding, the rates of 
chromophore release tested in a Meta II decay assay were similar 
for WT, EK, and KK rhodopsin samples (Supplemental Figure 1B), 
indicating that the E150K mutation did not perturb the activation 
of rhodopsin. Relative fluorescence measured to determine trans-
ducin (Gt) activation rates for WT, EK, and KK rhodopsin also 
provided similar results for these three genotypes (Supplemental 
Figure 1C). Interestingly, Gt activation rates were elevated slightly, 
but significantly (P < 0.005), by 1.3-fold for E150K mutant rhodop-
sin (KK mice) and 1.1-fold for rhodopsin from EK mice relative to 
WT rhodopsin. Biochemical characterization thus demonstrated 
that E150K mutant rhodopsin 
can activate Gt, and perhaps even 
at a slightly higher rate than WT 
rhodopsin. Because residue 150 
is located in the second cyto-
plasmic loop on top of helix IV, 
a region of rhodopsin important 
for dimerization and activation 
of Gt, crosslinking experiments to 
measure dimerization efficiency 
and the rates of Gt activation by 
E150K mutant rhodopsin were 
performed. Retinas isolated from 
WT, EK, and KK mice were incu-
bated with bifunctional Lys resi-
due crosslinkers dithiobis (suc-
cinimidyl) propionate (DSP) and 
disuccinimidyl glutarate (DSG) 
and bi-functional Cys residue 
crosslinker 3,6,9,12,15-penta-
oxaheptadecane-1,17-diyl bis-
methanethiosulfonate (MTS). 
Rhodopsin dimers and oligomers 
were formed concurrently with 
a decrease in the amount of rho-
dopsin monomer compared with 
the untreated control in all WT, 
EK, and KK rhodopsin samples 
(Supplemental Figure 2). No dif-
ferences in crosslinking properties 
among the rhodopsin samples 
were found, and it was also shown 
that the crosslinking resulted 
from the chemical reaction rather 
than nonspecific aggregation. 
The biochemical consequences 
of these findings on visual func-
tion were then investigated using 
various electrophysiological tech-
niques to assess photoresponses 
from the whole retina as well as 
those from isolated rods.
In vivo and ex vivo electroretino-
grams reveal attenuated signals in KK 
mice. In vivo electroretinogram 
(ERG) recordings (Figure 4, A 
and B, and Supplemental Figure 3A) from anesthetized 1- and 
2-month-old WT, EK, and KK mice revealed severely attenuated 
scotopic responses in KK mice by 2 months of age. Photopic vision 
was normal at this age (Figure 4, A and B), before completely dis-
appearing by 4 months of age (Supplemental Figure 3B). In con-
trast, both scotopic and photopic responses appeared normal in 
adult EK mice at 2 months of age (Figure 4B and Supplemental 
Figure 3). However, consistent with the progressive rod degenera-
tion in these animals (Figure 2B), their scotopic a-wave responses 
gradually declined with age compared with corresponding levels 
in WT mice. Scotopic b-waves of EK mice also showed progressive 
age-related decline, and eventually photopic b-waves were reduced 
as well (Supplemental Figure 3, B and C). The diminishing rates 
of scotopic and photopic vision correlated well with the differing 
Figure 2
E150K knock-in mice undergo progressive retinal degeneration. (A) Representative 3D OCT images of 
2-month-old WT and KK retinas. Scale bar: 20 μm. The ONL was substantially thinner in retinas of KK 
mice. (B) Thicknesses of the ONL measured 500 μm from the optic nerve head in nasal OCT images of 
genetically different mice as shown at various ages (n > 3). KK mice evidenced photoreceptor degenera-
tion by 1 month of age and had lost almost all their photoreceptors at the age of 4 months. (C) Plastic 
sections of retinas stained with toluidine blue from WT, EK, and KK mice at 1 and 4 months of age. EK 
retina displayed an intermediate progression of retinal degeneration indicated by modest degeneration 
by 4 months of age that progressed to nearly complete loss of photoreceptors by 10 months of age. (D) 
Numbers of nuclei per column in the superior-inferior and nasal-temporal axis of plastic sections crossing 
the optic nerve head in genetically different mice at 2 months of age (n = 3). WT and EK mouse retinas 
exhibited virtually identical numbers of nucleated photoreceptor cells, whereas there was substantial 
loss of photoreceptors in KK retina. No notable regional differences in degeneration were observed in KK 
retina. OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer.
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time courses of rod and cone cell degeneration, which are widely 
reported by many RP studies to reflect secondary cone photorecep-
tor degeneration after rod cell death (31, 32).
We performed ERG recordings from isolated mouse retinas to 
examine rod function in mutant mice in greater detail. Transreti-
nal ERG recordings were carried out with isolated portions of the 
retina, photoreceptor side up in a recording chamber, with elec-
trodes above and below the retina. This methodology allowed us to 
record events elicited following drug application over a long peri-
od and was used to detect stable photoresponses from scarce pho-
toreceptor populations. This approach allowed us to unmask the 
overall response generated by rods by pharmacologically blocking 
post-photoreceptor components of the ERG photoresponse (33). 
Using this strategy, we obtained families of rod flash responses 
recorded from WT, EK, and KK retinas from 3- to 5 week-old mice 
(Figure 4C). Replacing one copy of WT rhodopsin with its mutant 
E150K form resulted in a 21% reduction in the maximum rod 
response amplitude, whereas complete substitution resulted in a 
much more dramatic, 80% reduction (Figure 4, C and D). Consis-
tent with our in vivo ERG results, the maximal amplitude of the 
rod responses declined with age, and no responses were observed 
in KK animals older than 6 weeks of age (data not shown). We 
then fitted the corresponding normalized intensity-response rela-
tionship for each genotype with the hyperbolic Naka-Rushton 
function (see Methods for details) to estimate their photosensitiv-
ity, determined as half-saturating light intensity, I1/2 (Figure 4, D 
and E). Values for this parameter were essentially identical in EK 
compared with WT animals, 26.8 ± 0.6 photons/μm2 (n = 9) versus 
27.0 ± 0.4 photons/μm2 (n = 8), indicating normal rod sensitivity 
in EK mice. Surprisingly, despite the severe degeneration of KK 
rods, their normalized sensitivity was only slightly reduced, as 
their I1/2 increased by only 13%, to 31.0 ± 0.6 photons/μm2 (n = 9). 
This result supports the possibility that rod phototransduction 
was largely unaffected by the E150K rhodopsin mutation. The 
predominant fraction of chromophore-bound E150K opsin was 
confirmed electrophysiologically. Treatment of dark-adapted KK 
retinas with 11-cis-retinal did not increase their sensitivity rela-
tive to that of control KK retinas (Figure 4D). Thus, the level of 
free opsin in their rods, if any, was too low to produce detectable 
desensitization. For more refined analysis of phototransduction, 
we then turned to single-cell recordings.
Phototransduction efficiency is preserved in KK mice. To discriminate 
between photoreceptor degeneration and phototransduction 
deficiency, we carried out single-cell suction electrode recordings 
from rods of mice with differing genetic backgrounds to obtain 
families of flash responses from WT, EK, and KK retinas at 3–5 
month of age and analyze their properties (Figure 5A). The maxi-
mal response amplitude reflecting the size of the dark current, 
Idark, was reduced by 10% in EK rods and by 41% in KK rods on 
average relative to WT controls (Figure 5B and Table 2). Thus, 
the reduction in the number of functional rods and the decline 
in the dark current of individual cells contributed about equally 
to the 20% and 80% reduction in maximal transretinal rod ERG 
rod response observed in EK and KK retinas, respectively. In addi-
tion, the intensity-response curve of KK rods appeared somewhat 
shallower (Figure 5C), though the mechanism producing this 
Figure 3
Regeneration of opsin with 9-cis-retinal in retinas isolated from P30 WT, EK, and KK mice. (A) Isomeric analysis of retinoid oximes (OX) is shown 
for rhodopsin isolated from mouse retina incubated overnight with either 9-cis-retinal in PBS (right) or with PBS alone in a control experiment 
(left). Retinoids were identified based on their UV-visible spectra and order of elution from an HPLC column as compared with authentic stan-
dards. (B) Quantification of retinoids was achieved by correlating areas under chromatographic peaks with those generated by known amounts 
of synthetic standards.
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effect was not investigated. Notably, the normalized rod sensitiv-
ity estimated from the amplitude of dim flash responses divided 
by their flash strength and normalized to the corresponding dark 
current was comparable in WT, EK, and KK rods (Table 2). Con-
sistent with the normal sensitivity of EK rods, their normalized 
intensity-response curves overlapped completely with those of WT 
rods (Figure 5C), and their corresponding I1/2 values were also sim-
ilar (Table 2). The shallower intensity-response curve of KK rods 
resulted in a slightly higher I1/2 value (Table 2), although the dim 
flash section of the curve was identical to those of WT and EK rods 
(Figure 5C). Together, these results demonstrate that, despite its 
association with severe retinal degeneration, the mutant E150K 
rhodopsin was fully functional and could activate the rod photo-
transduction cascade as efficiently as WT rhodopsin.
We also examined the response kinetics of mutant rods. For all 
three mouse lines, we compared the averaged (cell population) 
means and normalized these to their corresponding dark-current 
dim flash responses. These responses were to flashes that sup-
pressed approximately 0.2 of the total rod dark current and fell 
within the linear range of the rod intensity-response relationship. 
Notably, the activation phase of the photoresponse, indicative of 
signal amplification during phototransduction, was unaffected 
by the E150K mutation (Figure 5D). Rather, the expression of the 
mutant rhodopsin resulted in broadening of the peak of the dim 
flash response and acceleration of its shutoff. The consequent 
increase in the time to peak, Tpeak, and acceleration of the recovery 
time constant, τrec, were especially pronounced in KK rods (Figure 
5D and Table 2). Finally, the dominant time constant of recovery 
from saturating flashes, τD, was also accelerated (Figure 5E and 
Table 2), suggesting accelerated transducin/phosphodiesterase 
(PDE) inactivation in the mutant rods (34).
E150K rhodopsin mutant has reduced thermal stability. To determine 
how the E150K mutation affects the thermal stability of rhodop-
sin, we measured time-dependent denaturation of rhodopsin 
from WT, EK, and KK mice in isolated retinas. After 5.5 hours 
of incubation at 60°C, E150K mutant rhodopsin lost approxi-
mately 81% of the chromophore, whereas rhodopsin from both 
WT and EK retinas lost approximately 68% of the chromophore 
Figure 4
In vivo ERG responses and transretinal rod ERG 
responses of WT, EK, and KK mice. (A) Repre-
sentative full-field scotopic and photopic ERG 
responses of anesthetized WT, EK, and KK mice at 
2 months of age show reduced scotopic responses, 
while photopic responses were still normal in KK 
as compared with WT mice. Scotopic and photopic 
responses were normal in EK mice. (B) Amplitudes 
of rod photoreceptor cell–evoked scotopic (left) 
a- and b-waves were reduced in KK mice, whereas 
cone photoreceptor cell–dependent photopic (right) 
a- and b-wave amplitudes were normal at 2 months 
of age (n > 4). Amplitudes of a- and b-waves under 
both scotopic and photopic conditions remained 
unchanged in EK mice. (C) Transretinal rod ERG 
responses from representative WT, EK, and KK 
retinas. Flash strengths were increased stepwise 
from 1.4 to 3,920 photons/μm2, by steps of 0.5 log 
units each (505 nm light). Red traces of WT, EK, and 
KK data represent responses to an identical light 
intensity (33 photons/μm2) for comparison. In these 
3 retinas, maximum responses were 185, 150, and 
23 μV, respectively. Absolute (D) and normalized 
(E) transretinal rod ERG response amplitudes as 
a function of flash strength are shown. Points were 
fitted with Naka-Rushton hyperbolic functions for 
WT (n = 8), EK (n = 9), and KK (n = 9) mice. The 
intensity-response relation is shown (in purple) for 
KK retinas treated with 130 μM 11-cis-retinal (1 hour, 
at room temperature) prior to recording (n = 4).
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(Figure 6A), indicating that the E150K mutant was less thermally 
stable. Interestingly, the greatest difference in rhodopsin stabil-
ity between KK and either WT or EK retinas occurred within the 
first 45 minutes of incubation, with further loss proceeding at a 
similar rate for all 3 rhodopsin samples.
Consistent with the reduced thermal stability of the E150K rho-
dopsin, we also observed increased dark cellular noise in our single-
cell recordings from mutant rods (Figure 6B). The greater sponta-
neous phototransduction activity of mutant rods was revealed by 
comparing the power spectra of WT and mutant rods after sub-
tracting the instrumental noise 
measured in bright, saturating 
light (Figure 6C). Mean variances 
(σ2) of the dark current increased 
from 0.015 ± 0.005 pA2 (n = 16) 
for WT rods to 0.030 ± 0.005 pA2 
(n = 16, P < 0.05) and 0.043 ± 0.005 
pA2 (n = 16, P < 0.001) for EK and 
KK rods, respectively. Thus, sub-
stituting E150K rhodopsin for 
its WT form increased the dark 
current variance 3-fold. Given the 
40% reduction in dark current of 
KK rods, this translates into an 
8.3-fold increase in rod sponta-
neous phototransduction activ-
ity. The changes in dark current 
might also be reflected by degen-
erative changes in mutant ROS. 
Therefore, in spite of minor varia-
tions of physiological responses, 
lack of a markedly dysfunctional 
phenotype for the E150K mutant 
rhodopsin suggested the patho-
physiology of disease could be 
driven by structural factors.
KK mice display disordered photo-
receptor disc structures that disrupt 
normal phagocytosis. Histological 
analysis of toluidine blue–stained 
retinas revealed characteristic 
round-shaped and denser stain-
ing of the entire nucleus (Figure 
7A, arrows), typical of pyknosis 
observed in light-induced photo-
receptor degeneration (35). Disor-
ganized photoreceptor cell outer 
segments also were noted, which 
prompted higher-resolution stud-
ies with transmission electron 
microscopy (TEM). Disorganized 
ROS were seen in retinas of P30 
KK mice and could be detected 
as early as P14. Compared with 
tightly packed discs in ROS from 
WT and EK mice, KK mice exhib-
ited disordered, loose disc archi-
tecture, as well as inclusion bodies 
with thick enveloping membranes 
(Figure 7B). Digestion of shed 
ROS by the RPE also seemed impaired in KK mice, which, unlike 
WT and EK mice, had undigested loose membrane structures in 
their RPE cells (Figure 7C). At 4 months of age, when degeneration 
of EK mouse retinas was evident and retinas from KK mice had 
lost almost all of their photoreceptors, deposits were found in the 
subretinal spaces of EK mouse retinas, and pigmented deposits 
were also seen in the subretinal space of KK mouse retinas. Some 
of the deposits resembled an activated microglial cell, as a nucleus 
was evident and appeared to have ingested some outer segments. 
Moreover, KK mouse retinas were devoid of photoreceptor disc 
Figure 5
Single-cell suction electrode responses of WT, EK, and KK rods from 3- to 5-week-old mice. (A) Families 
of single-cell responses from representative WT (left), EK (middle), and KK (right) rods. Flash strengths 
were increased from 0.9 to 706 photons/μm2, by single steps of 0.5 log units each (500 nm light). Red 
traces show responses to the identical light intensity (20 photons/μm2) for comparison. In these 3 cells, 
dark currents were 14.2, 13.0, and 8.9 pA, respectively. Absolute (B) and normalized (C) single-cell 
response amplitudes are shown as a function of flash strength. Points were fitted with Naka-Rushton 
hyperbolic functions. WT (n = 19), EK mutant (n = 19), KK mutant (n = 18) I1/2 levels are shown in Table 2. 
(D) Normalized single-cell dim flash responses (to light intensities of 7.6 photons/μm2) from dark-adapted 
WT, EK, and KK opsin mutant rods. Phototransduction activation was unaffected, but broadening of the 
response peak and acceleration of dim flash recovery (see Table 2) were observed in KK rods, whereas 
EK cells displayed an intermediate phenotype. (E) τD values from a series of supersaturating flashes. 
Linear fits through the data yielded τD values of 385 ± 23 ms (WT, n = 19), 292 ± 24 ms (EK, n = 19), and 
152 ± 14 ms (KK, n = 18). Recovery from saturating flashes was also accelerated in mutant photoreceptor 
cells. Data are mean ± SEM.
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structures at this age (Figure 7D). These structural defects could 
have profound effects not only on the photoreceptors, but also on 
the RPE layer, which must clear these aberrant discs by phagocyto-
sis. Therefore, to understand the effect of E150K mutant rhodop-
sin, we imaged the photoreceptor-RPE interface with serial block 
face scanning electron microscopy (SBF-SEM) of P14 KK mice 
(36, 37). A 15-μm-thick section of KK mouse retina outside of the 
optic nerve was sectioned 100 nm at a time. The resulting volume 
is shown in Figure 8A, with abnormal photoreceptor inclusions 
seen throughout the RPE layer highlighted in the 3D reconstruc-
tion of the RPE layer. This illustrates that this phenomenon seen 
in single TEM sections is a global phenotype of the E150K retina. 
Moreover, examination of the photoreceptors and the RPE cell 
they contact reveals the aberrant photoreceptor morphology that 
could give rise to pathological disc structures that must be pro-
cessed by the RPE (Figure 8B). Structural deformities induced by 
the E150K mutation leading to abnormal disc processing and sub-
retinal deposits could cause profound changes in retinal homoeo-
stasis that lead to immune activation. Therefore, we investigated 
retinal pathology in greater detail to determine whether immune 
activation could play a role in disease progression.
KK mice display rhodopsin mislocalization and retinal immune activa-
tion. Immunohistochemical staining of rod cells labeled with 1D4 
antibody (38) and nuclear layers labeled with DAPI revealed that 
by P30, the ROS and ONL of KK mice were shorter than those 
of WT and EK mice (Figure 2, Figure 9A, and Supplemental Fig-
ure 4). Though rhodopsin normally localizes in ROS, the mutant 
protein mislocalized in part to the inner segment and perinuclear 
region in KK mice (Figure 9A), an observation consistent with 
findings in cultured HEK293 cells (18). The decline in the photo-
receptor population was unique to rods, as immunohistochemical 
staining of cone cells labeled with peanut agglutinin (PNA) (35) 
revealed that cone cell numbers were similar to those in retinas of 
WT and EK animals (Supplemental Figure 4). Both real-time PCR 
and immunoblotting experiments on rhodopsin in retinal samples 
at P14, when KK mice still had the same number of rod cells as 
WT mice, revealed that rod opsin did not change at the transcrip-
tional level but instead decreased at the protein level in KK mice 
(Supplemental Figure 5, A and B). This indicates that the protein 
degradation machinery in rods was activated to eliminate mutant 
rhodopsin. In contrast, the amount of Gtα was not affected at the 
protein level in KK retina (Supplemental Figure 5B), indicating 
that degraded rhodopsin had no effect on other membrane-asso-
ciated or signaling proteins. By P30, the rhodopsin content in KK 
retina was about one-third that in WT or EK retina (Supplemental 
Figure 5C), which quantitatively correlates with the shortening of 
the ROS documented in KK mice.
Using scanning laser ophthalmoscopy (SLO) with an excitation 
wavelength of 490 nm and an emission filter of 500–700 nm, we 
detected autofluorescent spots in the retinal fundus of 2-month-
old EK and KK mice, with many more seen in the latter (Figure 
9B). Such spots were not detectable in the fundus of 1-month-old 
KK mice (data not shown). Because the observation of autofluo-
rescent spots by SLO can be attributable to possible inflamma-
tory activation in retinas of EK and KK mice (39, 40), we used 
immunohistochemistry to label and identify activated Müller cells 
with glial fibrillary acidic protein (GFAP) (41, 42) and macrophage/
microglia cells with ionized Ca2+-binding adaptor molecule 1 
(Iba1) (43). We found massive Müller cell activation in 1-month-
old KK mouse retina, as evidenced by increased GFAP staining 
(Figure 9C). In the WT retina, Iba1 labeling was seen only in the 
inner retina, but in KK retina, activated macrophages/microglia 
were also found in the outer segment/inner segment (OS/IS) of 
photoreceptor cells (Figure 9D), indicative of immune cell migra-
tion into the subretinal space.
Genetic manipulation of key visual cycle and phototransduction proteins 
highlights that the structural defect of KK mice leads to primary degenera-
tion. Mice with a knockout of the visual cycle enzyme lecithin-
retinol acyltransferase (Lrat) lack 11-cis-retinal for visual pigment 
regeneration, and rod cells of these mice undergo a slow degenera-
tion, usually after 2 months of age (44, 45). We investigated pho-
toreceptor cell survival in KK mice after genetic ablation of 11-cis-
retinal by cross-breeding them with Lrat–/– mice. In contrast to 
KK mice, retinal degeneration was less severe in KKLrat–/– mice, as 
manifested by a 2-fold increase in ONL thickness and rod photo-
receptor length at 2 months of age (Figure 10, A and B). KKLrat–/– 
retinas still underwent degeneration, with significantly decreased 
ONL thickness compared with that of age-matched Lrat–/– mice. A 
mouse with a knockout of the transducin α subunit (Gnat1), a key 
component for visual phototransduction in rods, was then used 
to investigate the role of phototransduction in KK rod degenera-
tion (46). By cross-breeding Gnat1–/– with KK mice, we found that 
photoreceptors degenerated faster in KK mice lacking phototrans-
duction. The ONL thickness was 33.0 ± 2.0 μm in KKGnat1–/– and 
43.3 ± 1.3 μm in KK retina based on OCT images at 1 month of 
age. But the ONL thickness of Gnat1–/– mice was 58.8 ± 1.6 μm, 
Table 2
Parameters of single-cell suction recordings
 Idark (pA) Tpeak (ms) Tintegr (ms) Sf(n) (μm2/ph) I1/2 (ph/μm2) n (I1/2) τrec (ms) τD (ms)
WT (19) 14.3 ± 0.5 139.0 ± 2.1 338.8 ± 21.6 2.6 × 10–2  26.5 ± 1.4 1.32 ± 0.02 217.8 ± 12.7 385.2 ± 23.3 
    ± 1.5 × 10–3
EK (19) 12.9 ± 0.4A 149.3 ± 2.0B 308.7 ± 21.4 2.7 × 10–2  27.1 ± 1.5 1.21 ± 0.03B 187.8 ± 15.9 292.1 ± 24.2B 
   (NS) ± 1.6 × 10–3 (NS)  (NS)   (NS)
KK (18) 8.4 ± 0.5C 166.2 ± 5.7C 250.5 ± 10.6C 2.7 × 10–2  45.2 ± 6.9A 1.12 ± 0.03C 116.4 ± 7.1C 152.3 ± 13.7C 
    ± 2.5 × 10–3 (NS)
Idark is the dark current measured from light-saturated responses; time to peak (Tpeak) andintegration time (Tintegr) refer to responses with amplitudes of 
approximately 0.2 Idark that fell within the linear range; Sf(n) is the normalized dim flash fractional sensitivity (amplitude of dim flash response divided by flash 
strength and then normalized for the amplitude of the saturating response); I1/2 represents the half-saturating light intensity; n (I1/2) is the Hill coefficient in 
the Naka-Rushton equation; τrec is the time constant representing the single-exponential decay of that dim flash response recovery phase; τD is the domi-
nant time constant of recovery after supersaturating flashes determined from the linear fit to time in a saturation versus intensity semilog plot. Values shown 
are mean ± SEM. AP < 0.05, BP < 0.01, CP < 0.001, compared with WT values.
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comparable to that of WT at this age (Figure 10, C and D). Taken 
together, these results indicate that apo-E150K opsin is toxic to 
rod cells, albeit less toxic than E150K rhodopsin, and the lack of 
phototransduction somehow accelerates retinal degeneration in 
these mutant mice. Most importantly, lack of a marked pheno-
typic change resulting from these genetic manipulations indicates 
that although the visual cycle and phototransduction can play 
a role in the retinal degeneration of E150K mice, the overriding 
force driving this degenerative phenotype is likely to be the struc-
tural destabilization caused by mutated E150K rhodopsin.
Discussion
The discovery of genetic disease mutations in humans is acceler-
ating in this age of high-throughput sequencing of both exons 
and whole genomes (47). However, the proper classification of 
these diseases as progressive or stationary, autosomal dominant 
or autosomal recessive, and their resulting treatments require the 
study of large cohorts of patients or appropriate animal models 
that mimic the human condition. To this end, we generated E150K 
opsin knock-in mice by replacing the endogenous opsin gene with 
a mouse opsin gene carrying the E150K mutation to study the 
pathophysiology of the first missense mutation associated with 
arRP. Retinas of KK transgenic mice failed to develop properly, and 
the ensuing retinal degeneration was rapid; almost all these pho-
toreceptor cells had degenerated by 4 months of age. Meanwhile, 
EK mice exhibited only a 20% decline in ONL length by 4 months 
of age, and photoreceptor cell degeneration did not fully progress 
until 10 months of age (Figure 2). The most striking phenotypic 
change was that even at an early age, photoreceptor outer segments 
were disorganized in KK mice (Figure 7). Disordered and loosened 
discs along with formation of inclusion bodies with thick envelopes 
apparently affected the RPE, where proper phagocytosis of ROS 
was compromised. Moreover, the mutated protein partially mislo-
calized to the inner segment and perinuclear regions of the retina in 
KK mice, possibly causing massive Müller cell activation indicative 
of retinal stress (Figure 9). Biochemical analyses indicated that the 
mutated opsin was properly folded and that chromophore binding 
and Meta II decay were not affected. However, rates of Gt activation 
by E150K rhodopsin were slightly elevated. Possibly because of the 
disorganized structure of ROS, the accessibility of visual chromo-
phore was affected in mutant mice such that a fraction of opsin in 
dark-adapted mouse rods was increased by 4%. Interestingly, genet-
ic elimination of chromophore production appeared to stabilize 
rods (Figure 10A). In contrast, genetic ablation of phototransduc-
tion accelerated retinal degeneration (Figure 10B).
Several types of electrophysiological recordings were used to 
evaluate how the E150K rhodopsin mutation affects visual func-
tion of knock-in mice. Scotopic ERG responses in vivo and from 
isolated retinas evidenced severely reduced signals in KK animals, 
consistent with severe retinal degeneration and disorganization 
of the ROS, even when photopic vision was only slightly affected. 
Moreover, both scotopic and photopic ERG signals declined as the 
degeneration progressed. But because normalized sensitivity was 
only slightly reduced, we believe that rod phototransduction was 
largely unaffected by the E150K rhodopsin mutation, an interpre-
tation supported by single-cell response recordings (Figure 5). The 
lack of proper structural organization and reduced volume of ROS 
could accelerate transducin/PDE inactivation in mutant rods, 
because recovery from both dim and saturating flashes was also 
accelerated (Figure 5, D and E). Based on our biochemical data, 
Figure 6
Thermal stability of rhodopsin in retinas isolated from P30 WT, EK 
and KK mice. (A) UV-visible absorbance spectra of rhodopsin in reti-
nal membrane suspensions measured at different time points after 
incubation at 60°C (0 minutes, 45 minutes, and 1.5, 2.5, 3.5, 4.5, and 
5.5 hours).Thermal decay of rhodopsin was determined by plotting 
the results based on 100% absorption at time 0. Error bars represent 
SD values estimated from 3 independent experiments. (B) Repre-
sentative current recordings from two sets of WT, EK, and KK rods in 
the dark and in saturating light that closed all cGMP-gated channels. 
(C) Difference power spectra (dark-light) reveal marked increases in 
cellular dark noise in the 0.5- to 20-Hz frequency range in KK mice. 
Data are mean ± SEM.
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the E150K mutant was less thermally stable, resulting in increased 
dark cellular noise in vivo (Figure 6) and an estimated 8.3-fold 
increase in rod spontaneous phototransduction activity.
Four major conclusions can be derived from the above evalua-
tions of retinal structure and function in KK and EK mice. The 
first involves the disease classification of EK mutant mice, in 
which retinal pathology and functional decline progressed with 
age. This is reminiscent of fundus albipunctatus caused by muta-
tions in the RDH5 gene and Oguchi disease involving mutations 
in arrestin and rhodopsin kinase that initially were considered 
stationary diseases in their homozygous forms. However, with 
better imaging and physiological measurements, both these 
diseases were found to be slowly progressive in terms of retinal 
degeneration and visual dysfunction because they emanated from 
mutations encoding key proteins of the visual cycle and photo-
transduction (48–50). These results along with the current study 
Figure 7
Photoreceptor and RPE structures in WT, EK, and KK mice. (A) Plastic sections of P30 KK mouse retinas stained with toluidine blue show dis-
organized photoreceptor OS with dying photoreceptor cells (arrows). Scale bar: 20 μm. (B) TEM images depict disordered photoreceptor OS 
discs in P30 KK mouse retina but not in retinas from WT or EK littermates. In WT and EK retinas, higher-magnification images reveal normal 
ROS architecture, whereas in the KK retina, there is severe ROS disorganization characterized by ROS with loosened and irregular shaped discs 
together with inclusions (arrows). Scale bars: 1 μm. (C) Phagosomes in P14 WT, EK, and KK RPE. Normal phagosomes were observed in P14 
WT and EK mouse RPE (boxes with dashed lines in the upper two rows; scale bar: 4 μm). Augmented phagosome images are shown in right 
panels. Scale bar, 1 μm. P14 KK mouse retinas display severe RPE pathology with undigested phagocytized discs (arrows, bottom panels) and 
even ingested discs show abnormal processing. (D) TEM images of retinas from 4-month-old WT, EK, and KK mice. Compared with WT retinas, 
EK retinas exhibit largely normal-appearing discs in most regions of the outer segment, with just a few abnormal deposits (*) in the subretinal 
space. KK mouse retinas completely lacked photoreceptor disc structures at this age (&) but pigmented deposits (#) are seen in their subretinal 
space. Scale bar: 5 μm. IS, photoreceptor inner segment.
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demonstrate that E150K retinopathy could similarly be properly 
classified as slowly progressing adRP. Thus, patients heterozygous 
for the E150K mutation should be encouraged to have their reti-
nal structure and function periodically reevaluated and treatment 
options appropriately adjusted when they become available.
Second, these E150K opsin mutant mice reveal much about 
the structure and organization of the ROS. Rhodopsin is essen-
tial for ROS formation; its lack does not allow formation of ROS 
from embryonic rod cells (21, 22). Increased or decreased expres-
sion of rhodopsin produces altered ROS sizes proportional to the 
amount of rhodopsin synthesized (19, 20). Moreover, disorga-
nization of ROS in mice with a positively charged residue in the 
E150K mutant contributes to disruption of the previously pro-
posed higher-order organization of rhodopsin (19, 23–25). This 
interpretation is compatible with results indicating that lack of a 
sufficient amount of rhodopsin due to aberrant transport would 
affect the size of ROS but not their structure, and thus would not 
cause ROS degeneration. But the E150K rhodopsin mutant also 
disrupts electrostatic interactions because of the substitution of a 
positively charged Lys for the negatively charged Glu residue. This 
in turn can lead to a different oligomeric structure documented 
by crosslinking of rhodopsin that does not support formation of 
ROS. This abnormal structure is manifested by altered biochemi-
cal properties, electrophysiological responses, abnormal internal 
disc structure, and aberrant shedding of ROS membranes.
Third, these mice provide information about the signaling prop-
erties of this mutant rhodopsin. Previous studies in cell culture 
systems showed that the E150K mutation caused accumulation 
of positive charges on the cytoplasmic surface of rhodopsin (17, 
18). Here, we demonstrate that mouse rods expressing E150K rho-
dopsin undergo severe and rapid retinal degeneration. As a result, 
the rod-driven light responses from EK and KK retinas declined by 
20% and 80%, respectively. Comparison of the response declines 
measured by transretinal and single-cell recordings indicated 
that a reduction in the number of functional rods and a decline 
in the dark current of individual rods contributed about equally 
to the overall reduction in rod-generated responses. Surprisingly, 
despite the severe degeneration of mutant rods, their normalized 
light sensitivity was essentially unaffected (Figures 4 and 5). More-
over, as demonstrated by the identical rising phases of their dim 
flash responses, amplification of the phototransduction cascade 
was normal in rods expressing the mutant rhodopsin (Figure 
5D). Thus, despite the disruption of electrostatic interactions and 
the severe retinal degeneration induced by this mutation, E150K 
rhodopsin could effectively trigger the phototransduction cas-
cade. This conclusion is supported by our direct measurements of 
transducin activation (Supplemental Figure 1C) showing that the 
E150K mutation not only failed to inhibit the activation of trans-
ducin but, in fact, even slightly enhanced it. Thus, we conclude 
that the E150K mutation does not affect the signaling properties 
of rhodopsin and the reduced function observed is due solely to 
mutant rod degeneration. Also seemingly related to ROS disor-
ganization is the somewhat faster response shutoff observed in 
mutant rods (Figure 5, D and E), indicative of their accelerated 
transducin/PDE inactivation.
The slight increase in the apoprotein opsin fraction in indepen-
dent experiments (Figure 3B) did not appear to reduce the dim 
flash sensitivity of mutant rods (Figure 4E). One possible explana-
tion is that the activity of E150K opsin might be lower than that of 
WT opsin, thus producing a minimal activation of the phototrans-
duction cascade in the mutant rods. However, a more likely sce-
nario is that this increased opsin fraction is too small to reduce the 
sensitivity of mutant rods, as treatment of KK retinas with endog-
enous 11-cis-retinal failed to increase their sensitivity (Figure 4D).
A physiologically relevant change in the properties of this 
mutant opsin was a reduction in its thermal stability (Figure 6A). 
Consistent with this result, we also observed a 3-fold increase in 
cellular noise exhibited by mutant KK rods (Figure 6, B and C), 
indicating an 8.3-fold increase in rod spontaneous phototransduc-
tion activity. However, it is currently unclear what fraction of this 
increase was due to the increased spontaneous activation of E150K 
rhodopsin and what fraction, if any, was due to changes in basal 
phototransduction activity associated with the degenerative mor-
phological changes in the ROS.
Finally, the E150K mouse opsin mutant displayed differences 
in stability after genetically induced ablation of the visual cycle 
Figure 8
SBF-SEM highlights global pathological effects of the 
E150K mutation on photoreceptors and the RPE of the P14 
KK retina. (A) SBF-SEM was carried out involving 100-nm 
serial sections of a 15-μm-deep volume of the KK retina. A 
3D representation of the retina (abnormal disc inclusions 
in the RPE are indicated by yellow arrows) is shown in the 
upper part, with resulting reconstructions of the RPE cells 
depicted in different colors and abnormal disc inclusions 
inside the cell denoted by brown-filled volumes shown in 
the lower part. The center RPE cell has a characteristic 
hexagonal shape shown in more detail in B, where different 
areas of that reconstructed RPE cell (gray, nucleus in blue) 
highlight representative abnormal disc inclusions indicated 
in the raw SEM image by yellow arrow. Abnormal photo-
receptor packing (photoreceptors in green with the abnor-
mal 1 colored red) is also seen in the raw SEM image with 
the abnormal photoreceptor indicated by a yellow asterisk. 
Scale bars: 1 μm.
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of phototransduction that have potential implications for the 
treatment of retinal diseases. We genetically eliminated the reti-
noid cycle, the process that regenerates the light-sensitive chro-
mophore 11-cis-retinal (51, 52). In contrast to adRP-causing opsin 
gene mutations P23H (29) and T4R (18, 53), the E150K mutant 
opsin appears more stable under such conditions, inducing a 
milder retinal disease phenotype than these counterparts. This 
could be attributed to the profound oligomerization of opsin ver-
sus rhodopsin that could preferentially benefit the E150K mutant 
ROS. In contrast, ablation of phototransduction accomplished 
by genetic removal of the Gtα (54) slightly accelerated degenera-
tion of E150K retina. Although we do not yet understand why this 
occurs, a reasonable speculation favors an ion flow imbalance in 
a highly compromised ROS structure. Our genetic results suggest 
that, in contrast to other models of RP, exposure to moderate light 
could be beneficial. Moreover, higher expression of WT rhodopsin 
in E150K mutant mice with stabilization of the oligomeric rho-
dopsin structure could also improve ROS stability. In conclusion, 
this work highlights the importance of generating proper animal 
models of even rare variants of RP to study their pathophysiology 
in vivo and emphasizes that a structural abnormality (in oligomer-
ization of rhodopsin resulting in abnormal assembly of the ROS) 
is the primary defect induced by the E150K mutation.
Methods
Animals. E150K knock-in mice used in this study were generated by inGe-
nious Targeting Laboratories. C57BL/6J WT mice (Jackson Laboratory) 
were used for crossbreeding with E150K mice. Lrat–/– (44, 55) and Gnat1–/– 
mice (54) also were employed for crossbreeding experiments. Lack of rd/rd 
and rd8 mutations in these animals was verified by using published 
methods (56, 57). Mice were routinely maintained in a 12-hour light (<10 
lux)/12-hour dark cycle, with ad libitum access to food and water.
Chemicals and antibodies. 11-cis-retinal was a gift from R. Crouch (Universi-
ty of South Carolina School of Medicine, Columbia, South Carolina, USA), 
and 9-cis-retinal was purchased from Toronto Research Chemical. DSP and 
DSG were purchased from Thermo Scientific. MTS was purchased from 
Santa Cruz Biotechnology Inc.
1D4 mouse mAb was obtained from R. Molday (University of British 
Columbia, Victoria, British Columbia, Canada) (58) (5 mg/ml; 1:100,000 
dilution for immunoblotting, 1:10,000 for immunohistochemistry); 
B6-30 mAb was a gift from P. Hargrave (University of Florida, Gaines-
ville, Florida, USA) (59) (1 mg/ml; 1:4,000 for immunoblotting, 1:400 
Figure 9
Rhodopsin mislocalization, fundus autofluorescent spots, 
and Müller/macrophage/microglial cell activation in retinas 
of KK mice. (A) E150K rhodopsin probed with 1D4 antibody 
mislocalized in part to the inner segment and perinuclear 
region of 1-month-old mouse retina. In contrast, rhodopsin 
localized normally within the ROS of WT and EK retina. (B) 
SLO fundus images from WT, EK, and KK mice at 2 months 
of age. Numerous autofluorescent spots are evenly distrib-
uted throughout the KK mouse fundus, whereas autofluores-
cence is barely visible in WT fundus. EK fundus exhibited a 
moderate fluorescent phenotype. (C) Immunohistochemistry 
of 1-month-old WT, EK, and KK mouse retinas with GFAP 
antibody that labels activated Müller cells. Massive activation 
of Müller cells is evident in KK but not in WT or EK retina. (D) 
Immunohistochemical analysis of 1-month-old WT, EK, and 
KK mouse retinas with Iba1 antibody (green) used to mark 
macrophage or microglia. In WT and EK retinas, Iba1 immu-
noreactivity was observed only in the ganglion cell layer 
(GCL) to the OPL, whereas in KK retina, Iba1 labeling also 
localized to the outer photoreceptor cell layer (arrows). DAPI 
was used to counterstain nuclei. All immunohistochemistry 
was done with retinas from 1-month-old mice. Scale bars: 
40 μm. IS, photoreceptor inner segment.
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for immunohistochemistry); biotinylated PNA was purchased from Vec-
tor Laboratories (1:400 for immunohistochemistry); rabbit anti-GFAP 
polyclonal antibody (pAb) was from Dako (1:400 for immuno histo-
chemistry); rabbit anti-Iba1 pAb was obtained from Wako (1:400 for 
immuno histochemistry); sc389 anti-Gαt1 pAb was purchased from Santa 
Cruz Biotechnology Inc. (1:5,000 for immunoblotting); and AC-15 anti– 
β-actin mAb was purchased from Abcam (1:5,000 for immunoblotting).
Generation of E150K knock-in mice. E150K knock-in mice were generated 
as follows: a 7.75-kb region used to construct the targeting vector was first 
subcloned from a positively identified C57BL/6 (RP23: 88A11) BAC clone. 
As shown in Figure 1C, the construct was designed as follows: the short 
homology arm (SA) extended about 2.11 kb 5′ to a loxP-flanked Neo cas-
sette inserted 183 bp upstream of exon 2; the target region of 284 bp con-
tained the loxP-Neo cassette and exon 2 with a point mutation engineered 
by overlap extension PCR to introduce a G>A mutation that caused a Glu 
to Lys residue alteration in codon 150; and the long homology arm (LA) of 
5.36 kb then was located 3′ to exon 2. This BAC construct was subcloned 
into an approximately 2.4-kb backbone vector (pSP72, Promega) contain-
ing an ampicillin selection cassette for transformation of the construct 
prior to electroporation. The targeting vector was linearized by NotI and 
then transfected by electroporation into iTL BA1 (C57BL/6 × 129/SvEv) 
hybrid ES cells. After selection with G418 antibiotic (Sigma-Aldrich), sur-
viving clones were expanded for PCR analysis to identify recombinant ES 
clones. Clone 734, confirmed as correctly targeted, was then electroporated 
with a Cre-expressing vector to eliminate the Neo cassette. Electroporated 
clones were grown in G418-free medium. After targeted hybrid ES cells 
from Neo-deleted clone 181 were microinjected into C57BL/6 blastocysts, 
the resulting chimeric mice with a high percentage of agouti coat color 
were mated with WT C57BL/6 mice to generate F1 heterozygous founders. 
Three founders and their offspring were then identified by PCR of their 
genomic DNA obtained from tail biopsies with a forward primer (NDEL1, 
5′-AGGCTGACATATGGACTAATGTCTGG-3′) and a reverse primer 
(NDEL2, 5′-GCTAGGATGCAAGCTTCTGGTTTG-3′) (Figure 1D).
Opsin locus sequencing. A approximately 1-cm tail snip from an F2 homozy-
gous E150K mouse was incubated overnight at 55°C with 20 mg/ml pro-
teinase K (Fisher Scientific) in 500 μl proteinase K buffer (50 mM Tris, 100 
mM NaCl, 10 mM EDTA, 1% SDS, pH 8.0). Initially, 250 μl of supersatu-
rated NaCl was added to each sample to solubilize proteins. Then 250 μl 
chloroform was added as an organic layer. After shaking and centrifuga-
tion, a supernatant was obtained that contained genomic DNA. One mil-
liliter of cold 100% ethanol was added to genomic DNA precipitated from 
500 μl supernatant. The precipitated DNA was rinsed twice with 70% etha-
nol and then dissolved in nuclease-free water. The opsin locus, including 
the entire targeted region, was amplified by using Takara LA Taq DNA 
polymerase (Takara) with the primers A4, 5′-GTCTCCATAGCCCATGGT-
CATCCCTC-3′ and B4, 5′-AGGCAGGAGTAAAGATGACACCCCAC-3′. 
Resulting amplified PCR products (8.3 kb) were gel purified and sequenced 
with DNA sequencing primers at approximately 700-bp intervals.
Opsin cDNA fragment cloning. Retinas from EK mice at P15 were dissolved 
in 400 μl TRI Reagent (Applied Biosystems). Total RNA, extracted accord-
ing to the manufacturer’s instructions, was dissolved in 50 μl RNase-free 
water, and contaminating genomic DNA was removed by RNase-free 
DNase RQ1 (Promega). cDNA was synthesized with the Power SYBR Green 
PCR Master Mix (Applied Biosystems) according to the manufacturer’s 
instructions. The same amount of total RNA was processed without reverse 
transcriptase as a negative control. PCR was performed by using GoTaq 
Figure 10
Effects of genetic depletion of 11-cis-retinal 
production or absence of rod phototransduc-
tion on retinal degeneration in KK mice. (A) 
Plastic sections of retinas crossing the optic 
nerve head of 2-month-old KK and KKLrat–/– 
mice. Sections were stained with toluidine 
blue (upper panels). KKLrat–/– retina showed 
increased number of rows of photoreceptor cell 
nuclei as compared with age-matched KK reti-
na. This finding is consistent with the increased 
thickness of the ONL in KKLrat–/– retina shown 
in the corresponding SD-OCT images (lower 
panels). (B) Thickness of the ONL in KK, 
KKLrat–/–, and Lrat–/– mice measured at 500 
μm from the optic nerve head of nasal OCT 
images (n > 3). Depletion of 11-cis-retinal par-
tially protected against retinal degeneration in 
KK mice. (C) SD-OCT images of retinas cross-
ing the optic nerve head from 1-month-old KK 
and KKGnat1–/– mice. KKGnat1–/– retina dis-
played decreased thickness of ONL relative 
to an age-matched KK retina. (D) Thickness of 
the ONL in KK, KKGnat1–/–, and Gnat1–/– mice 
measured 500 μm from the optic nerve head 
in nasal OCT images (n > 3). Absence of the 
Gtα caused greater retinal degeneration in KK 
mice. *P < 0.05, **P < 0.01. Scale bars: 20 μm.
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through an ethanol series (50%, 70%, 80%, 90%, 95%, and 100%), transi-
tioned to epoxy embedding medium with propylene oxide, and embedded 
for sectioning in Eponate 812. Sections for morphological study were cut 
at 1 μm with a microtome (Leica RM2255) and stained with toluidine blue. 
Digital images were captured with a Leica DMI 6000 B inverted microscope. 
For EM studies, ultrathin sections (70 nm) were prepared with an ultra-
microtome (Reichert-Jung Ultracut E), stained with uranyl acetate, and 
adsorbed onto carbon grids. A Tecnai T12 electron microscope (FEI) oper-
ating at 120 kV or 200 kV with a LaB6 filament was used for final imaging.
SBF-SEM, data analysis, and 3D reconstructions. Blocks prepared for TEM 
were used for SBF-SEM. The sample was prepared and cut using a Quanta 
200 (FEI) with Gatan 3View software as described previously (37). Serial 
sectioning was performed on the block face by cutting a 100-nm slice from 
the face with a diamond knife and imaging the freshly cut block from the 
backscattered electron signal. This process was automated to collect 200 
successive images over approximately 12 hours. Imaging was performed at 
an accelerated voltage of 3 kV in a low-vacuum mode (0.23 Torr) at 4,096- 
by 4,096-pixel resolution, with a pixel size of 17 nm.
After serial sectioning, images were viewed with Fiji-win32 (a version of 
ImageJ) and merged to form a stack. The stack was registered and aligned 
to account for drift that could have occurred during the experiment. The 
registered stack was then opened using the Reconstruct program (62), and 
structural elements were mapped to provide 3D reconstructions.
Purification of rhodopsin from mouse eyes. Eyes from two 4-week-old dark-
adapted WT, EK, and KK mice were collected and used immediately for 
rhodopsin purification or stored at –80°C. Eyes were homogenized with a 
hand-held glass homogenizer in 2 ml buffer composed of 20 mM Bis-Tris 
propane (BTP), pH 7.5, 150 mM NaCl, 1 mM EDTA, and protease inhibi-
tors. The homogenate was centrifuged at 25,000 g in a benchtop centrifuge 
for 15 minutes at 4°C. The supernatant was discarded, and the pellet was 
suspended in buffer composed of 20 mM BTP, pH 7.5, 150 mM NaCl, and 
20 mM n-dodecyl-β-d-maltoside (DDM) (Affymetrix) and incubated at 
room temperature for 1 hour. The sample then was centrifuged at 100,000 g 
for 45 minutes at 4°C. The supernatant was incubated with 0.5 ml of 1D4 
immunoaffinity resin equilibrated with buffer composed of 20 mM BTP, 
pH 7.5, 150 mM NaCl, and 2 mM DDM for 1 hour at room temperature. 
This resin was loaded into a column and washed with 10 ml of the above 
buffer. Rhodopsin then was eluted from the column with equilibrating 
buffer supplemented with 800 μM 1D4 peptide (TETSQVAPA). The absor-
bance spectrum of purified rhodopsin was obtained with a Cary50 UV-
visible spectrophotometer. The concentration of rhodopsin was calculated 
by measuring the absorbance at 500 nm and using a molar extinction coef-
ficient of 40,600 M–1cm–1 (63). Rhodopsin photoactivation was achieved 
by illuminating samples for 5 minutes with a Fiber-Lite illuminator (Dolan 
Jenner Industries) through a 480–520 nm band-pass filter.
Meta II decay. Meta II decay rate determinations were performed accord-
ing to a tryptophan fluorescence method described previously (64). All 
measurements were done with 30 nM rhodopsin dissolved in buffer con-
sisting of 20 mM BTP, pH 6.0, 100 mM NaCl, and 1 mM DDM which 
favors formation of Meta II, the activated form of rhodopsin. Rhodopsin 
was bleached for 15 seconds with a 150-W Fiber-Lite illuminator through 
a 480–520 nm band-pass filter. Intrinsic tryptophan fluorescence was then 
immediately monitored with a PerkinElmer LS 55 fluorescence spectro-
photometer at an excitation wavelength of 295 nm (2.5-nm slit) and an 
emission wavelength of 330 nm (5-nm slit). The temperature of the cuvette 
was maintained at 20°C with a circulating water bath. The increase in tryp-
tophan fluorescence correlated with the release of all-trans-retinal from the 
binding pocket of rhodopsin. Fluorescence data were analyzed with Sigma-
Plot (Systat Software Inc.) by nonlinear regression fitting to an equation 
describing first-order reaction kinetics to obtain the time constant τ.
Flexi DNA polymerase (Promega) with primers Rho-cDNA-F2, 5′-CTTCG-
GAGGATTCACCACCACCC-3′ and Rho-cDNA-R2, 5′-CAATCCCGCAT-
GAACATTGCATGCC-3′. The 308-bp predicted PCR products were not 
generated by negative controls involving either non-reverse-transcribed 
total RNA or water as templates (data not shown). After purification by 
a Wizard SV gel and PCR clean-up system (Promega), PCR products were 
ligated into pGEM-T Easy vector (Promega) and transfected into JM109 
cells (Promega). Sequencing was used to determine the presence of WT 
and E150K opsin fragments; examples of sequence chromatograms from 
mouse ID L1R1 are shown in Figure 1E. To assess the ratio between E150K 
and WT opsin mRNA, we sequenced 129 cDNA clones from 3 EK mice and 
calculated the WT to E150K opsin cDNA ratios (Table 1).
Ultra-high-resolution SD-OCT and SLO imaging. For all in vivo imaging, mice 
were anesthetized by intraperitoneal injection of a cocktail (10 μl/g body 
weight) containing ketamine (10 mg/ml) and xylazine (0.4 mg/ml) in PBS 
(HyClone Laboratories). Pupils were dilated with 1% tropicamide (Bausch 
and Lomb). Ultra-high-resolution SD-OCT (Bioptigen) was employed 
for imaging (60). Four pictures acquired in the B-scan mode were used to 
construct each final averaged 2D SD-OCT image, and the rectangular vol-
ume scan mode was used to construct 3D images. The Heidelberg Retinal 
Angiograph II (Heidelberg Engineering) was employed for SLO imaging.
Immunohistochemistry. Mouse eye cups were fixed with 4% para formal-
dehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 2 hours at 4°C. 
Fixed tissues were dehydrated with 30% sucrose in PBS, embedded in 
O.C.T. sucrose mixture (1:1 O.C.T./30% sucrose in PBS), and then frozen 
as described previously (61). Cryosections (12 μm thick) were cut with a 
cryostat-microtome (CM1850, Leica); incubated with primary antibodies 
1D4, PNA, GFAP, or Iba1 (see Chemicals and antibodies for more informa-
tion); and visualized with anti-mouse, goat anti-rabbit Alexa Fluor 488– or 
Cy3–conjugated IgGs (1:500, Jackson ImmunoResearch Laboratories Inc.) 
or Alexa Fluor 488–conjugated streptavidin (1:500, Invitrogen). Fluores-
cence was detected with a fluorescence microscope (CTR 6000, Leica). 
Images captured with a CCD camera (Retiga EXi Fast 1394, QImaging) 
were analyzed with Adobe Photoshop software.
Immunoblotting. Retinas from both eyes of a mouse were homoge-
nized in ice-cold RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium 
deoxycholate, 0.1% SDS, and 50 mM Tris, pH 8.0) with protease inhibitors 
(Sigma-Aldrich). Protein concentrations were measured with a Pierce BCA 
assay kit (Thermo Scientific). Protein (15 μg) from each sample was trans-
ferred to immunoblot-PVDF membranes for SDS-PAGE gel electrophore-
sis. Primary antibodies identical to those used for immunohistochemistry 
were detected by incubation with goat anti-rabbit or anti-mouse secondary 
antibodies conjugated with horseradish peroxidase (1:2,000). Anti–β-actin 
(AC-15, Abcam) was employed for the loading control.
Real-time (RT)-PCR. Total RNA from mouse retinas was isolated with 
TRI Reagent (Applied Biosystems), and possible contaminating genomic 
DNA was removed by RNase-free DNase I (Promega). Total RNA (1 μg) 
was reverse transcribed with a high-capacity cDNA reverse transcription 
kit (Applied Biosystems) in a total volume of 20 μl. Then 0.5% of this reac-
tion mixture was used as a template for a RT-PCR reaction with Taqman 
Gene Expression Assays (Applied Biosystems) following the manufactur-
er’s instructions. Mm00520345_m1 was used to probe rhodopsin, with 
the 18S rRNA (4319413E) probe set (Applied BioSystems) employed as an 
endogenous control. All real-time experiments were done with the Applied 
BioSystems Step-One Plus RT-PCR machine.
Histology: light and transmission electron microscopy. Mouse eyecups were first 
fixed overnight by immersion in 5% glutaraldehyde/4% paraformaldehyde, 
pH 7.4, at 4°C. Then they were washed with 0.13 M sodium phosphate, pH 
7.3, and secondarily fixed with 1% OsO4 in 0.1 M sodium phosphate, pH 7.4, 
for 2 hours at room temperature. Eye cups subsequently were dehydrated 
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The MTS Cys residue bifunctional crosslinker was solubilized in DMSO 
to a final concentration of 25 mM (stock solution) and diluted ×62.5 to 
a final concentration of 400 μM in the crosslinking reaction. This reac-
tion was carried out for 1 hour on ice and then quenched by adding 0.5 M 
N-ethylmaleimide to a final concentration of 20 mM. In control samples, 
the DSP and MTS samples were treated with 100 mM DTT after crosslink-
ing to cleave the disulfide linkages. The resulting crosslinking of rhodopsin 
was checked by immunoblotting with anti-rhodopsin B6-30 antibody.
Mouse ERGs. All ERG procedures were performed according to published 
methods (67). For single-flash recording, the duration of white-light flash 
stimuli (from 20 μs to 1 ms) was adjusted to provide a range of illumi-
nation intensities (from –3.7 to 1.6 log cd×s/m2). Three to 5 recordings 
were made at sufficient intervals between flash stimuli (from 3 seconds to 
1 minute) to allow recovery from any photobleaching effects.
Transretinal ERG recordings. Three- to 5-week-old WT, EK, and KK mice 
were dark-adapted overnight and sacrificed by CO2 asphyxiation, and their 
retinas were removed under infrared illumination and stored in oxygen-
ated aqueous L15 (13.6 mg/ml, pH 7.4, Sigma-Aldrich) solution containing 
0.1% BSA at room temperature. A single retina was mounted on filter paper 
with the photoreceptor side up and placed on the recording chamber with 
an electrode connected to the bottom of the perfusion chamber. A second 
electrode was placed just above the center of the retina, which was perfused 
with Locke’s solution (112.5 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 
1.2 mM CaCl2, 10 mM HEPES, pH 7.4, 20 mM NaHCO3, 3 mM Na suc-
cinate, 0.5 mM Na glutamate, 0.02 mM EDTA, and 10 mM glucose). This 
solution was supplemented with 2 mM l-glutamate and 10 μM DL-AP-4 to 
block higher-order components of the photoresponse (68); 20 μM BaCl2 to 
suppress the glial component (69); and MEM vitamin and amino acid solu-
tions (Sigma-Aldrich) to retain retinal viability. The perfusion solution was 
continuously bubbled with a 95% O2/5% CO2 mixture heated to 36–37°C. 
The solution in the lower electrode compartment (140 mM NaCl, 3.6 mM 
KCl, 2.4 mM MgCl2, 1.2 mM CaCl2, 3 mM HEPES, 10 mM glucose, pH 7.4) 
also contained 2 mM l-glutamate and 10 mM BaCl2.
Light stimulation was applied as 20-ms test flashes of calibrated 505-nm 
LED light. For light uniformity, a glass optical diffuser was placed between 
the LED and the retina. The stimulating light intensity was controlled by 
neutral density filters and a computer in 0.5 log unit steps. Photoresponses 
were amplified by a differential amplifier (DP-311; Warner Instruments), 
low-pass filtered at 30 Hz (8-pole Bessel), digitized at 1 kHz, and stored in 
a computer for further analysis. The intensity-response relationships for 
both single-cell and transretinal recordings were fitted with Naka-Rushton 
hyperbolic functions, as follows:
  (Equation 1) 
for fitting absolute data, or 
  (Equation 2) 
for fitting normalized data — where R is the transient-peak amplitude of 
response, Rmax is the maximal response amplitude, I is the flash intensity, n is 
the Hill coefficient (exponent), and I1/2 is the half-saturating light intensity.
Single-cell suction recordings. Three- to 5-week-old WT, EK and KK mice 
were dark-adapted overnight and sacrificed by CO2 asphyxiation, and their 
retinas were removed under infrared illumination, chopped into small 
pieces, and transferred to a perfusion chamber located on the stage of an 
inverted microscope. Then a single ROS was drawn into a glass microelec-
trode filled with a solution containing 140 mM NaCl, 3.6 mM KCl, 2.4 mM 
Gt activation. The functionality of rhodopsin purified from mouse retinas 
was evaluated by a Gt activation fluorescence assay. The molar ratio of Gt to 
Rho was 10:1 at concentrations of 250 nM and 25 nM, respectively. Protein 
samples were diluted in 20 mM BTP buffer, pH 7.0, containing 120 mM 
NaCl, 2 mM MgCl2 and 1 mM DDM and then exposed to light for 15 sec-
onds with a Fiber-Lite covered with a band-pass wavelength filter (480–520 
nm). The reaction was carried out at 20°C in a continuously stirred cuvette. 
After 300 seconds of incubation, 5 M GTPγS was added. The intrinsic 
increase in fluorescence emanating from Gαt was measured with a Perki-
nElmer LS55 luminescence spectrophotometer employing excitation and 
emission wavelengths of 300 and 345 nm, respectively (65, 66). No changes 
in tryptophan fluorescence were detected in control experiments without 
GTPγS. A pseudo-first-order kinetic rate constant (k) was derived from the 
following function: A(t) = Amax(1 – exp–kt), where Amax is the maximal Gαt 
fluorescence change and A(t) is the relative fluorescence change at time t.
Opsin regeneration with 9-cis-retinal and retinoid analyses. Retinas were isolated 
from dark-adapted WT, EK, and KK mice, and each retina was incubated 
with 50 μM 9-cis-retinal in 200 μl PBS overnight in the dark on ice. The 
next day, the PBS buffer with excess 9-cis-retinal was discarded, and retinas 
were suspended in buffer composed of 20 mM BTP, pH 7.5, containing 
150 mM NaCl and protease inhibitors and homogenized with an Eppen-
dorf homogenizer. This solution was supplemented with 20 mM DDM 
and incubated for 1 hour on ice to solubilize membranes. Samples were 
centrifuged at 100,000 g for 45 minutes. Collected supernatants were 
incubated with 250 μl 1D4-immunoaffinity resin pre-equilibrated with 
20 mM BTP, pH 7.5, 150 mM NaCl, and 2 mM DDM for 1 hour at room 
temperature. Then the resin was loaded into a column and washed exten-
sively with 25 ml of the above buffer. To separate retinoids from rhodop-
sin bound to the 1D4 resin, protein was first denatured for 30 minutes 
with 50% CH3OH in the presence of 40 mM NH2OH. The resulting reti-
nal oximes were extracted with 600 μl hexane, and their isomeric content 
was determined by normal-phase HPLC with an Ultrasphere-Si, 5 μm, 
4.5 × 250 mm column (Beckman). Retinoids, eluted isocratically with 
10% ethyl acetate in hexane at a flow rate of 2 ml/min, were detected by 
absorption at 360 nm. These were quantified by correlating areas under 
their chromatographic peaks with those generated from known amounts 
of synthetic standards.
Thermal stability of rhodopsin. The thermal stability of rhodopsin was mea-
sured in retinas isolated from WT, EK and KK mice. Four to 10 retinas 
were suspended in 1.6 ml buffer composed of 20 mM BTP, pH 7.4, and 
100 mM NaCl; homogenized with an Eppendorf homogenizer on ice; 
and then centrifuged at 1,000 g for 2 minutes at 4°C to remove unho-
mogenized tissue. The resulting membrane suspension was placed in an 
incubator at 60°C. Then at 0 minutes, 45 minutes, 1.5 hours, 2.5 hours, 
3.5 hours, 4.5 hours, and 5.5 hours, 200-μl aliquots were collected and 
quickly solubilized with 20 mM DDM, and their absorbance was recorded. 
Resulting absorbance values at 500 nm were employed to create a plot 
of rhodopsin’s thermal decay. Standard deviations were calculated from 
3 sets of experimental data.
Chemical crosslinking of rhodopsin. Crosslinking reactions of rhodopsin were 
performed with retinas isolated from WT, EK, and KK mice. Retinas were 
washed twice in the crosslinking buffer composed of 100 mM Na2HPO4, 
pH 8.3, containing 150 mM NaCl, and then single retinas were gently 
homogenized in 200 μl of the same buffer. Unhomogenized tissue was 
removed by brief centrifugation at 1,000 g for 2 minutes. The homobifunc-
tional Lys residue crosslinkers DSP and DSG were solubilized in DMSO to 
a final concentration of 50 mM (stock solutions) and then diluted ×50 to 
achieve a 1-mM concentration (~400 fold molar excess) in the crosslinking 
reaction. Crosslinking reactions were performed for 1 hour on ice and termi-
nated by adding 1 M Tris/HCl, pH 7.5, to a final concentration of 100 mM. 
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conformed to both the recommendations of the American Veterinary Medi-
cal Association Panel on Euthanasia and the Association of Research for 
Vision and Ophthalmology.
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MgCl2, 1.2 mM CaCl2, 3 mM HEPES, pH 7.4, 0.02 mM EDTA, and 10 mM 
glucose. The perfusion Locke’s solution (see previous section) was bubbled 
with a 95% O2/5% CO2 mixture and heated to 37–38°C.
Light stimuli were applied in 20-ms test flashes of calibrated 500-nm 
light. Photoresponses were amplified, low-pass filtered (30 Hz, 8-pole Bes-
sel), and digitized (1 kHz). Normalized dim flash fractional sensitivity 
(Sf(n)) was calculated from the linear region of the intensity-response curve 
as the ratio of the response amplitude to flash strength and then normal-
ized by the amplitude of the saturating response. I1/2 was calculated from 
the intensity-response relationship as the test flash intensity required to 
produce a response with an amplitude equal to half of the corresponding 
saturated response amplitude. Integration time (Tintegr) was calculated as 
the integral of the dim flash response with the transient peak amplitude 
normalized to unity. The time constant for the dim flash response recovery 
(τrec) was derived from the best single-exponential fit to the declining phase 
of the response. The dominant recovery time constant (τD) was determined 
from supersaturating flashes (70), by using a 10% criterion for photocur-
rent recovery from saturation. Data were analyzed with Clampfit 10.2 
(Molecular Devices) and Origin 8.5 software (OriginLab).
Statistics. Data representing the mean ± SEM (unless otherwise men-
tioned) are presented for the results of at least 3 independent experiments 
compared by 2-tailed Student’s t test. Differences with P values less than 
0.05 were considered statistically significant.
Study approval. All animal procedures and experiments were approved by 
the CWRU and the Washington University Animal Care Committees and 
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